Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
Autophagy, the intracellular lysosomal degradation process plays a pivotal role in podocyte homeostasis in diabetic kidney disease (DKD). Lysosomal function, autophagic activity, and their actions were investigated in vitro and in vivo. We found that LC3-II- and p62-positive vacuoles accumulated in podocytes of patients with DKD. Moreover, we found that advanced glycation end products (AGEs) could increase the protein expression of LC3-II and p62 in a dose- and time-dependent manner in cultured podocytes. However, the mRNA expression of LC3B, Beclin-1 or ATG7, as well as the protein level of Beclin-1 or ATG7 did not change significantly in the AGE-treated cells compared with that in control groups, suggesting that AGEs did not induce autophagy. In addition, AGEs led to an increase in the number of autophagosomes but not autolysosomes, accompanied with a failure in lysosomal turnover of LC3-II or p62, indicating that the degradation of autophagic vacuoles was blocked. Furthermore, we observed a dramatic decrease in the enzymatic activities, and the degradation of DQ-ovalbumin was significantly suppressed after podocytes were treated with AGEs. Plasma-irregular lysosomal-associated membrane protein 1 granules accompanied with the diffusion of cathepsin D expression and acridine orange redistribution were observed in AGE-treated podocytes, indicating that the lysosomal membrane permeability was triggered. Interestingly, we also found that AGEs-induced autophagic inhibition and podocyte injury were mimicked by the specific lysosomotropic agent, l-leucyl-l-leucine methyl ester. The exacerbated apoptosis and Rac-1-dependent actin-cytoskeletal disorganization were alleviated by an improvement in the lysosomal-dependent autophagic pathway by resveratrol plus vitamin E treatment in AGE-treated podocytes. However, the rescued effects were reversed by the addition of leupeptin, a lysosomal inhibitor. It suggests that restoring lysosomal function to activate autophagy may contribute to the development of new therapeutic strategies for DKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures












Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“One study also demonstrated that advanced glycation end-products (AGEs) impaired autophagy in podocytes by inducing lysosomal dysfunction127.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [127]
The cited source says what the claim attributes to it.
In the citing paper
“Kidney biopsy samples from patients with diabetes also indicated that autophagy was reduced in podocytes compared with kidney specimens from patients with mild urinary protein excretion or only haematuria”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [127]
In the citing paper
“Treatment with the antioxidants resveratrol and vitamin E restored lysosomal function and rescued the impairment in autophagy, thereby attenuating AGE-induced podocyte injury.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578
Methods in Mammalian Autophagy Research
Mizushima, N., Yoshimori, T., & Levine, B. (2010) · Cell · doi:10.1016/j.cell.2010.01.028 · Cited by 4,497
Autophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608
Kimura, S., Noda, T., & Yoshimori, T. (2007) · Autophagy · doi:10.4161/auto.4451 · Cited by 2,278
Lysosomal membrane permeabilization in cell death
Boya, P., & Kroemer, G. (2008) · Oncogene · doi:10.1038/onc.2008.310 · Cited by 1,426
Monitoring and Measuring Autophagy
Yoshii, S. R., & Mizushima, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091865 · Cited by 1,107
Podocyte loss and progressive glomerular injury in type II diabetes.
Pagtalunan, M. E., Miller, P. L., Jumping-Eagle, S., Nelson, R. G., Myers, B. D., Rennke, H. G., Coplon, N. S., Sun, L., & Meyer, T. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119163 · Cited by 1,088
ROS, mitochondria and the regulation of autophagy
Scherz-Shouval, R., & Elazar, Z. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.07.009 · Cited by 954
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.001 · Cited by 890
Hartleben, B., Gödel, M., Meyer-Schwesinger, C., Liu, S., Ulrich, T., Köbler, S., Wiech, T., Grahammer, F., Arnold, S. J., Lindenmeyer, M. T., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39492 · Cited by 721
Synaptopodin: An Actin-associated Protein in Telencephalic Dendrites and Renal Podocytes
Mundel, P., Heid, H. W., Mundel, T. M., Krüger, M., Reiser, J., & Kriz, W. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.1.193 · Cited by 592
From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease
Wolf, G., Chen, S., & Ziyadeh, F. N. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1626 · Cited by 565
TFEB and TFE3: Linking Lysosomes to Cellular Adaptation to Stress
Raben, N., & Puertollano, R. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125407 · Cited by 437
Rusmini, P., Cortese, K., Crippa, V., Cristofani, R., Cicardi, M. E., Ferrari, V., Vezzoli, G., Tedesco, B., Meroni, M., Messi, E., et al. (2019) · Autophagy · doi:10.1080/15548627.2018.1535292 · Cited by 436
Advanced glycation end products in the pathogenesis of chronic kidney disease
Rabbani, N., & Thornalley, P. J. (2018) · Kidney International · doi:10.1016/j.kint.2017.11.034 · Cited by 387
Autophagy in human type 2 diabetes pancreatic beta cells
Masini, M., Bugliani, M., Lupi, R., del Guerra, S., Boggi, U., Filipponi, F., Marselli, L., Masiello, P., & Marchetti, P. (2009) · Diabetologia · doi:10.1007/s00125-009-1347-2 · Cited by 360
Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
Calcutt, N. A., Cooper, M. E., Kern, T. S., & Schmidt, A. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2476 · Cited by 352
At the end of the autophagic road: an emerging understanding of lysosomal functions in autophagy
Shen, H.-M., & Mizushima, N. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.12.001 · Cited by 336
Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy
Tagawa, A., Yasuda, M., Kume, S., Yamahara, K., Nakazawa, J., Chin-Kanasaki, M., Araki, H., Araki, S.-I., Koya, D., Asanuma, K., et al. (2016) · Diabetes · doi:10.2337/db15-0473 · Cited by 315
AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions
Sanajou, D., Ghorbani Haghjo, A., Argani, H., & Aslani, S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.001 · Cited by 313
Lenoir, O., Jasiek, M., Hénique, C., Guyonnet, L., Hartleben, B., Bork, T., Chipont, A., Flosseau, K., Bensaada, I., Schmitt, A., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1049799 · Cited by 296
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
Molitch, M. E., Adler, A. I., Flyvbjerg, A., Nelson, R. G., So, W.-Y., Wanner, C., Kasiske, B. L., Wheeler, D. C., de Zeeuw, D., & Mogensen, C. E. (2015) · Kidney International · doi:10.1038/ki.2014.128 · Cited by 268
Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential
Yang, D., Livingston, M. J., Liu, Z., Dong, G., Zhang, M., Chen, J.-K., & Dong, Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2639-1 · Cited by 252
Fang, L., Zhou, Y., Cao, H., Wen, P., Jiang, L., He, W., Dai, C., & Yang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060546 · Cited by 228
Autophagy and kidney inflammation
Kimura, T., Isaka, Y., & Yoshimori, T. (2017) · Autophagy · doi:10.1080/15548627.2017.1309485 · Cited by 224
Obesity-Mediated Autophagy Insufficiency Exacerbates Proteinuria-induced Tubulointerstitial Lesions
Yamahara, K., Kume, S., Koya, D., Tanaka, Y., Morita, Y., Chin-Kanasaki, M., Araki, H., Isshiki, K., Araki, S.-I., Haneda, M., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012111080 · Cited by 213
Lysosomal Function and Dysfunction: Mechanism and Disease
Boya, P. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4405 · Cited by 212
Podocyte Biology and Pathogenesis of Kidney Disease
Reiser, J., & Sever, S. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-050311-163340 · Cited by 209
Podocytes: the Weakest Link in Diabetic Kidney Disease?
Lin, J. S., & Susztak, K. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0735-5 · Cited by 189
Song, X.-B., Liu, G., Liu, F., Yan, Z.-G., Wang, Z.-Y., Liu, Z.-P., & Wang, L. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.262 · Cited by 186
Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance
Tian, X., Kim, J. J., Monkley, S. M., Gotoh, N., Nandez, R., Soda, K., Inoue, K., Balkin, D. M., Hassan, H., Son, S. H., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69778 · Cited by 163
Nutrient Sensing, Autophagy, and Diabetic Nephropathy
Kume, S., Thomas, M. C., & Koya, D. (2012) · Diabetes · doi:10.2337/db11-0555 · Cited by 157
Osicka, T. M., Houlihan, C. A., Chan, J. G., Jerums, G., & Comper, W. D. (2000) · Diabetes · doi:10.2337/diabetes.49.9.1579 · Cited by 150
Liu, W. J., Shen, T. T., Chen, R. H., Wu, H.-L., Wang, Y. J., Deng, J. K., Chen, Q. H., Pan, Q., Huang Fu, C.-M., Tao, J.-L., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.666354 · Cited by 132
Self-citationMechanism of apoptosis induced by a lysosomotropic agent, L-Leucyl-L-Leucine methyl ester
Uchimoto, T., Nohara, H., Kamehara, R., Iwamura, M., Watanabe, N., & Kobayashi, Y. (1999) · APOPTOSIS · doi:10.1023/a:1009695221038 · Cited by 122
Takahashi, A., Takabatake, Y., Kimura, T., Maejima, I., Namba, T., Yamamoto, T., Matsuda, J., Minami, S., Kaimori, J.-Y., Matsui, I., et al. (2017) · Diabetes · doi:10.2337/db16-0397 · Cited by 122
Zhou, L., Cao, W., Xie, C., Tian, J., Zhou, Z., Zhou, Q., Zhu, P., Li, A., Liu, Y., Miyata, T., et al. (2012) · Kidney International · doi:10.1038/ki.2012.184 · Cited by 121
p62/SQSTM1 in autophagic clearance of a non-ubiquitylated substrate
Watanabe, Y., & Tanaka, M. (2011) · Journal of Cell Science · doi:10.1242/jcs.081232 · Cited by 99
Emerging role of podocyte autophagy in the progression of diabetic nephropathy
Yasuda‒Yamahara, M., Kume, S., Tagawa, A., Maegawa, H., & Uzu, T. (2015) · Autophagy · doi:10.1080/15548627.2015.1115173 · Cited by 97
Autophagy activation reduces renal tubular injury induced by urinary proteins
Liu, W. J., Luo, M.-N., Tan, J., Chen, W., Huang, L.-Z., Yang, C., Pan, Q., Li, B., & Liu, H.-F. (2014) · Autophagy · doi:10.4161/auto.27004 · Cited by 93
Self-citationRapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice
Xiao, T., Guan, X., Nie, L., Wang, S., Sun, L., He, T., Huang, Y., Zhang, J., Yang, K., Wang, J., et al. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2090-7 · Cited by 85
Liu, W. J., Xu, B., Ye, L., Dong, L., Wu, H.-L., Zheng, Y., Deng, J. K., Li, B., & Liu, J. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00383.2014 · Cited by 78
Self-citationInhibition of autophagy increased AGE/ROS-mediated apoptosis in mesangial cells
Xu, L., Fan, Q., Wang, X., Zhao, X., & Wang, L. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.322 · Cited by 76
Khatami, P. G., Soleimani, A., Sharifi, N., Aghadavod, E., & Asemi, Z. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.02.021 · Cited by 71
Liu, N., Xu, L., Shi, Y., & Zhuang, S. (2017) · Journal of Diabetes Research · doi:10.1155/2017/3560238 · Cited by 68
(Pro)renin receptor regulates autophagy and apoptosis in podocytes exposed to high glucose
Li, C., & Siragy, H. M. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00603.2014 · Cited by 45
Asadi, S., Moradi, M. N., Kheiripour, N., Goodarzi, M. T., & Mahmoodi, M. (2016) · Biological Trace Element Research · doi:10.1007/s12011-016-0861-6 · Cited by 35
Active autophagy but not lipophagy in macrophages with defective lipolysis
Goeritzer, M., Vujić, N., Schlager, S., Chandak, P. G., Korbelius, M., Gottschalk, B., Leopold, C., Obrowsky, S., Rainer, S., Doddapattar, P., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.06.005 · Cited by 30
Erythropoietin protects lipopolysaccharide-induced renal mesangial cells from autophagy
Bi, L., Hou, R., Da-sheng, Y., Li, S., & Zhao, D. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.2124 · Cited by 13
Cited by
Autophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
Mechanisms of podocyte injury and implications for diabetic nephropathy
Barutta, F., Bellini, S., & Gruden, G. (2022) · Clinical Science · doi:10.1042/cs20210625 · Cited by 221
“On the other hand, studies in both patients with DN and podocytes exposed to AGEs suggest that autophagy blockade due to lysosomal dysfunction rather than autophagy deficiency is the major abnormality in DN [224].”
Critical Role for AMPK in Metabolic Disease-Induced Chronic Kidney Disease
Juszczak, F., Caron, N., Mathew, A. V., & Declèves, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217994 · Cited by 157
Barutta, F., Bellini, S., Kimura, S., Hase, K., Corbetta, B., Corbelli, A., Fiordaliso, F., Bruno, S., Biancone, L., Barreca, A., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2080382 · Cited by 141
“Moreover, disruption of the autophagy-lysosome pathway by AGE-BSA was described in both podocytes and tubular epithelial cells [61,68].”
BackgroundProgrammed Cell Death in Diabetic Nephropathy: A Review of Apoptosis, Autophagy, and Necroptosis
Erekat, N. S. (2022) · Medical Science Monitor · doi:10.12659/msm.937766 · Cited by 106
“Likewise, an in vitro study showed that underexpression of Beclin-1 in podocytes eventually caused albumin leakage [128].”
Background
Metadata
- Authors
- Liu, W. J., Gan, Y., Huang, W. F., Wu, H.-L., Zhang, X.-Q., Zheng, H. J., & Liu, H.-F.
- Affiliations
- Guangdong Medical College (CN)
- Venue
- Cell Death & Disease
- Published
- 2019-10-24
- Volume
- 10
- Issue
- 11
- Pages
- 806-806
- ISSN
- 2041-4889 (ISSN-L)
- PMC
- PMC6813305
- OpenAlex
- W2982228087
- Cited by
- 88
- References
- 51
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 21 · 2023: 6 · 2022: 18 · 2021: 18 · 2020: 8
- FWCI
- 8.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cell Death and Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (81570656)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- diabetic nephropathy, podocytes, autophagy, lysosomal dysfunction, advanced glycation end products, LC3-II, p62, autophagosomes, lysosomal membrane permeability, lysosomotropic agents, resveratrol, vitamin E, Rac1, actin cytoskeleton, podocyte injury, LAMP1
- MeSH terms
- Autophagy, Diabetic Nephropathies, Humans, Lysosomes, Podocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.